Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

2-FLUORO-N-METHYL-4-NITROBENZAMIDE

2-FLUORO-N-METHYL-4-NITROBENZAMIDE Structure
  • ₹0
  • Product name: 2-FLUORO-N-METHYL-4-NITROBENZAMIDE
  • CAS: 915087-24-0
  • MF: C8H7FN2O3
  • MW: 198.15
  • EINECS:
  • MDL Number:MFCD09909407
  • Synonyms:2-FLUORO-N-METHYL-4-NITROBENZAMIDE;N-Methyl-2-fluoro-4-nitrobenzamide;BenzaMide, 2-fluoro-N-Methyl-4-nitro-;1. 2-fluoro-N-Methyl-4-nitrobenzaMide;4-Nitro-2-fluoro-N-MethylbenzaMide;2-FLUORO-N-METHYL-4-MITROBENZAMIDE
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Boiling point :337.1±32.0 °C(Predicted)
Density :1.358
storage temp. :Sealed in dry,Room Temperature
pka :12.77±0.46(Predicted)

Safety Information

Symbol(GHS): GHS hazard pictogramsGHS hazard pictograms
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H228 Flammable solid Flammable solids Category 1
Category 2
Danger
Warning
GHS hazard pictograms P210, P240,P241, P280, P370+P378
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P210 Keep away from heat/sparks/open flames/hot surfaces. — No smoking.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

2-?Fluoro-?N-?methyl-?4-?nitrobenzamide is used in the preparation of androgen receptor antagonists MDV3100. MDV3100 is also a clinical candidate for the treatment of hormone refractory prostrate cancer.

Related product price